Vaccine: DCGI panel to meet Bharat Biotech officials shortly
By IANS |
Published on
Sat, Jan 2 2021 12:36 IST |
0 Views
Vaccine: DCGI panel to meet Bharat Biotech officials shortly. Image Source: IANS News
New Delhi, Jan 2 : A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its Covaxin to get the go-ahead, a top source said.
On Friday, the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) had held that the data provided by Bharat Biotech for its coronavirus vaccine was not sufficient for the grant of approval for emergency use and sought more information.
URL copied
A health worker gets a shot of the vaccine. (Representational image)
Given that India has set the goal of vaccinating 30 crore people with Covid-19 jabs by July, can the country procure enough doses to fulfill that goal? To vaccinate 30 crore people, the country will need 60 crore doses as the two vaccines that are leading the race to get approval from the government require two-doses per person for protection.
These two vaccines that the government is currently considering giving the approval are Covishield and Covaxin .
While the Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing Covishield , Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for Covaxin .
COVID vaccine dry-run kicks off, Kerala Health Minister says state ready for vaccination drive
The dry-run, aimed to assess the ability of the health system to administer vaccine shots to the selected groups, is being carried out at six centres spreading over four districts in the state.
Share Via Email
| A+A A-
Healthcare workers seen holding the COVID-19 vaccine during a dry run at the Peroorkada Governement Hospital on Saturday morning. (Photo | Vincent Pulickal, EPS) By Express News Service
On Saturday, the state became part of the COVID-19 vaccine dry-run being organized at the national level. The dry-run, aimed to assess the ability and readiness of the health system to administer vaccine shots to the selected groups, is being carried out at six centres spreading over four districts in the state.
Does India have the doses to fulfil Phase-1 Covid vaccine goals? daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
The committee of experts assessing Coronavirus vaccines had called Hyderabad-based Bharat Biotech for a meeting in the afternoon today, a day after the firm was asked to present more data to get a nod, a top source said Saturday.
Friday, the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) had held that the data provided by Bharat Biotech for its Coronavirus vaccine is not sufficient for grant of emergency use approval and asked for more information.